These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28159773)

  • 1. Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis.
    Edwards A; Gao Y; Allan RN; Ball D; de Graaf H; Coelho T; Clifford V; Curtis N; Williams A; Faust SN; Mansour S; Marshall B; Elkington P; Tebruegge M
    Thorax; 2017 Oct; 72(10):946-949. PubMed ID: 28159773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays.
    Clifford V; Zufferey C; Germano S; Ryan N; Leslie D; Street A; Denholm J; Tebruegge M; Curtis N
    Tuberculosis (Edinb); 2015 May; 95(3):343-9. PubMed ID: 25837441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.
    Jung YJ; Woo HI; Jeon K; Koh WJ; Jang DK; Cha HS; Koh EM; Lee NY; Kang ES
    PLoS One; 2015; 10(10):e0141033. PubMed ID: 26474294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Vortia E; Uko VE; Yen-Lieberman B; Frawley J; Worley SE; Danziger-Isakov L; Kaplan B; Mahajan L
    Inflamm Bowel Dis; 2018 Mar; 24(4):877-882. PubMed ID: 29562270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
    Hatzara C; Hadziyannis E; Kandili A; Koutsianas C; Makris A; Georgiopoulos G; Vassilopoulos D
    Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
    Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
    PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.
    Chang B; Park HY; Jeon K; Ahn JK; Cha HS; Koh EM; Kang ES; Koh WJ
    Clin Rheumatol; 2011 Dec; 30(12):1535-41. PubMed ID: 21556777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
    Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
    Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In Tube in the diagnosis of pulmonary tuberculosis].
    Wang XY; Su BY; Chen ZY; Kuang HB; Guan P; Cao ZZ; Tan YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):445-452. PubMed ID: 35527459
    [No Abstract]   [Full Text] [Related]  

  • 18. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
    Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
    J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.